180 related articles for article (PubMed ID: 26135849)
1. One-year swallowing outcomes following transoral laser microsurgery +/- adjuvant therapy versus primary chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma.
O'Hara J; Goff D; Cocks H; Moor J; Hartley C; Muirhead C; Patterson J
Clin Otolaryngol; 2016 Apr; 41(2):169-75. PubMed ID: 26135849
[TBL] [Abstract][Full Text] [Related]
2. Transoral laser microsurgery ± adjuvant therapy versus chemoradiotherapy for stage III and IVA oropharyngeal squamous cell carcinoma: Preliminary comparison of early swallowing outcomes.
O'Hara J; Cosway B; Muirhead C; Leonard N; Goff D; Patterson J
Head Neck; 2015 Oct; 37(10):1488-94. PubMed ID: 24891273
[TBL] [Abstract][Full Text] [Related]
3. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
4. Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers.
More YI; Tsue TT; Girod DA; Harbison J; Sykes KJ; Williams C; Shnayder Y
JAMA Otolaryngol Head Neck Surg; 2013 Jan; 139(1):43-8. PubMed ID: 23247974
[TBL] [Abstract][Full Text] [Related]
5. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
[TBL] [Abstract][Full Text] [Related]
6. Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study.
Goff D; Coward S; Fitzgerald A; Paleri V; Moor JW; Patterson JM
Clin Otolaryngol; 2017 Dec; 42(6):1135-1140. PubMed ID: 28128886
[TBL] [Abstract][Full Text] [Related]
7. Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer.
Rich JT; Liu J; Haughey BH
Laryngoscope; 2011 Nov; 121(11):2381-90. PubMed ID: 21882203
[TBL] [Abstract][Full Text] [Related]
8. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
[TBL] [Abstract][Full Text] [Related]
9. Functional swallowing outcomes following treatment for oropharyngeal carcinoma: a systematic review of the evidence comparing trans-oral surgery versus non-surgical management.
Dawe N; Patterson J; O'Hara J
Clin Otolaryngol; 2016 Aug; 41(4):371-85. PubMed ID: 26292983
[TBL] [Abstract][Full Text] [Related]
10. Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach.
Wilkie MD; Upile NS; Lau AS; Williams SP; Sheard J; Helliwell TR; Robinson M; Rodrigues J; Beemireddy K; Lewis-Jones H; Hanlon R; Husband D; Shenoy A; Roland NJ; Jackson SR; Bekiroglu F; Tandon S; Lancaster J; Jones TM
Head Neck; 2016 Aug; 38(8):1263-70. PubMed ID: 27042800
[TBL] [Abstract][Full Text] [Related]
11. Transoral laser microsurgery and radiotherapy for oropharyngeal squamous cell carcinoma: Equitable survival and enhanced function compared with contemporary standards of care.
Dalton CL; Milinis K; Houghton D; Ridley P; Davies K; Williams R; Hamilton D; Wilkie MD; Markey A; Clarke K; Lofthouse M; Helliwell TR; Triantafyllou A; Rodrigues J; Bheemireddy K; Hanlon R; Wieshmann H; Haridass A; Brammer C; Husband D; Shenoy A; Loh C; Roland NJ; Bekiroglu F; Tandon S; Lancaster J; Jones TM
Eur J Surg Oncol; 2020 Nov; 46(11):2042-2049. PubMed ID: 32893045
[TBL] [Abstract][Full Text] [Related]
12. Comparison of functional outcomes and quality of life between transoral surgery and definitive chemoradiotherapy for oropharyngeal cancer.
Chen AM; Daly ME; Luu Q; Donald PJ; Farwell DG
Head Neck; 2015 Mar; 37(3):381-5. PubMed ID: 24431059
[TBL] [Abstract][Full Text] [Related]
13. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.
Rich JT; Milov S; Lewis JS; Thorstad WL; Adkins DR; Haughey BH
Laryngoscope; 2009 Sep; 119(9):1709-19. PubMed ID: 19572271
[TBL] [Abstract][Full Text] [Related]
14. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia.
Barbon CEA; Peterson CB; Moreno AC; Lai SY; Reddy JP; Sahli A; Martino R; Johnson FM; Fuller CD; Hutcheson KA
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):956-964. PubMed ID: 36074459
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of transoral laser microsurgery for oropharyngeal squamous cell carcinoma in Ireland and review of the literature on transoral approaches.
Woods RSR; Geyer L; Ionescu A; Callanan D; Sheahan P
Ir J Med Sci; 2019 May; 188(2):397-403. PubMed ID: 29926338
[TBL] [Abstract][Full Text] [Related]
16. Prospective analysis of functional swallowing outcome after resection of T2 glottic carcinoma using transoral laser surgery and external vertical hemilaryngectomy.
Nasef HO; Thabet H; Piazza C; Del Bon F; Eid M; Banna ME; Nicolai P
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2133-40. PubMed ID: 27117690
[TBL] [Abstract][Full Text] [Related]
17. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.
Owadally W; Hurt C; Timmins H; Parsons E; Townsend S; Patterson J; Hutcheson K; Powell N; Beasley M; Palaniappan N; Robinson M; Jones TM; Evans M
BMC Cancer; 2015 Aug; 15():602. PubMed ID: 26311526
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma.
Sievert M; Goncalves M; Zbidat A; Traxdorf M; Mueller SK; Iro H; Gostian AO
Auris Nasus Larynx; 2021 Apr; 48(2):295-301. PubMed ID: 32883577
[TBL] [Abstract][Full Text] [Related]
19. Association Between Objective Ratings of Swallowing and Dysphagia-Specific Quality of Life in Patients Receiving (Chemo)radiotherapy for Oropharyngeal Cancer.
Wishart LR; Harris GB; Cassim N; Alimin S; Liao T; Brown B; Ward EC; Nund RL
Dysphagia; 2022 Aug; 37(4):1014-1021. PubMed ID: 34625841
[TBL] [Abstract][Full Text] [Related]
20. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.
Goepfert RP; Lewin JS; Barrow MP; Fuller CD; Lai SY; Song J; Hobbs BP; Gunn GB; Beadle BM; Rosenthal DI; Garden AS; Kies MS; Papadimitrakopoulou VA; Schwartz DL; Hutcheson KA
Laryngoscope; 2017 Apr; 127(4):842-848. PubMed ID: 27440393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
